Mario Raviǵlione

7 ta ish

University of Milan

1. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

   Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori

   Sharh maqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.133230

2. Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis

   Marcos Espinal, Sang‐Jae Kim, Pedro Suarez +7

   Maqola20003 iqtibos

   ABIABI:AkademIndex/2026.other.020025

3. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

   Dennis Falzon, E. Jaramillo, Holger J. Schünemann +43

   MaqolaOAOchiq kirish20113 iqtibos

   ABIABI:AkademIndex/2026.other.169932

4. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

   Tadayuki Tanimura, Ernesto Jaramillo, Diana Weil +2

   Sharh maqolaOAOchiq kirish20142 iqtibos

   ABIABI:AkademIndex/2026.other.006844

5. The Growing Burden of Tuberculosis

   Elizabeth L. Corbett, Catherine Watt, Neff Walker +4

   Sharh maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.020028

6. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?

   Hoang Thi Quy, Nguyễn Thị Ngọc Lan, Martien W. Borgdorff +7

   Maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.020034

7. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010

   Matteo Zignol, Wayne Van Gemert, Dennis Falzon +4

   MaqolaOAOchiq kirish20112 iqtibos

   ABIABI:AkademIndex/2026.other.169933